LFSTNasdaqServices-Health ServicesFiscal year ends December 31

LifeStance Health Group, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$11.77+0.03 (+0.26%)

Close on Oct 19, 2026

Market cap: $4.56B
P/E (TTM): 90.5
Dividend yield: –

LifeStance Health Group, Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2019 2019-12-31
Depreciation & Amortization	42	41	37	29	15	3.04
Stock-Based Compensation	75	76	99	187	259	0.05
Deferred Income Taxes	2.02	-0.96	-22	-17	-27	1.85
Other Non-Cash Items	-2.03	-1.43	-7.08	-0.22	0	–
Change in Accounts Receivable	36	-6.40	-24	-22	-24	-5.76
Change in Accounts Payable	-1.56	0.50	-5.61	7.67	0.62	2.54
Operating Cash Flow	146	107	-17	53	9.42	17
Capital Expenditures	-36	-22	-41	-79	-94	-14
Acquisitions	0	0	-20	-60	-100	-59
Investing Cash Flow	-36	-22	-60	-139	-194	-73
Debt Issued	0	288	58	257	99	56
Debt Repaid	-7.25	-289	-2.47	-188	-311	-0.49
Taxes Paid on Share-Based Awards	-8.71	0	0	-0.90	0	0
Financing Cash Flow	-16	-9.95	47	47	314	48
Net Change in Cash	94	76	-30	-39	129	-7.86
Free Cash Flow	110	86	-57	-26	-85	2.73
Income Taxes Paid	1.57	0.06	0.08	2.24	1.09	0.25
Interest Paid	18	25	21	14	22	4.58

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: 4.9%
Net margin: 3.2%
Return on equity, FY2025: 0.7%

Financial strength

Current ratio: 1.38
Debt to equity: 0.19
Debt to assets: 12.5%
Cash to current liabilities: 82.2%

Valuation

P/E ratio: 90.5
Price to sales: 2.88
Price to book: 3.09
Dividend yield: –